Publisher
Springer Science and Business Media LLC
Reference43 articles.
1. Marshall R, Tlagadi A, Bronze M, Kana V, Naidoo S, Wiggill T, et al. Lower frequency of NPM1 and FLT3-ITD mutations in a South African adult de novo AML cohort. Int J Lab Hematol. 2014;36(6):656–64.
2. Feng J-H, Guo X-P, Chen Y-Y, Wang Z-J, Cheng Y-P, Tang Y-M. Prognostic significance of IDH1 mutations in acute myeloid leukemia: a meta-analysis. Am J Blood Res. 2012;2(4):254.
3. Ilyas AM, Ahmad S, Faheem M, Naseer MI, Kumosani TA, Al-Qahtani MH, et al. Next generation sequencing of acute myeloid leukemia: influencing prognosis. BMC Genomics. 2015;16(1):S5.
4. Sayar H, Bashardoust P. Therapies for acute myeloid leukemia: vosaroxin. Onco Targets Ther. 2017;10:3957.
5. Li Y, Zhu B. Acute myeloid leukemia with DNMT3A mutations. Leukemia Lymphoma. 2014;55(9):2002–12.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献